Arrowhead Pharmaceuticals
ARWR
#2228
Rank
S$11.19 B
Marketcap
S$79.92
Share price
-0.19%
Change (1 day)
213.06%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): S$0.19 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are S$0.82 Billion. In 2024 the company made an earning of -S$0.76 Billion a decrease over its 2023 earnings that were of -S$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.19 B-125.71%
2024 -S$0.76 Billion112.45%
2023 -S$0.36 Billion87.79%
2022 -S$0.2 Billion-20.1%
2021 -S$0.24 Billion67.59%
2020 -S$0.15 Billion-347.53%
2019 S$57.33 M-245.59%
2018 -S$39.39 Million-13.17%
2017 -S$45.36 Million-52.28%
2016 -S$95.06 Million-16.57%
2015 -S$0.12 Billion30.32%
2014 -S$87.43 Million171.62%
2013 -S$32.19 Million16.56%
2012 -S$27.62 Million107.53%
2011 -S$13.31 Million
2008 -S$46.88 Million-8.07%
2007 -S$50.99 Million70.37%
2006 -S$29.93 Million122.51%
2005 -S$13.45 Million147.41%
2004 -S$5.44 Million2002.28%
2003 -S$0.26 Million-85.61%
2002 -S$1.8 Million1371.97%
2001 -S$0.13 Million-13.45%
2000 -S$0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$40.92 B 22,893.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$3.98 Billion-2,332.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$84.37 M-52.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.15 Billion-183.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.16 B-7.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-S$0.14 Billion-176.72%๐Ÿ‡บ๐Ÿ‡ธ USA